The past three years have been a roller coaster for Abbott Laboratories (NYSE: ABT). The healthcare giant dealt with a slowdown in its medical device business caused by the pandemic, fluctuating sales of its coronavirus diagnostic tests, and a recall of some of its baby formula products. Abbott's financial results haven't been consistent, partly explaining why it has lagged the market this year.

However, there remain excellent reasons to buy shares of the company. Let's consider why Abbott Labs is an outstanding "forever" stock. 

Continue reading

Source Fool.com